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WE have. observed that FK S06 (FK) preve~ted the inductIon of hyperacute reJectIOn (HAR) In ham-
ster-to-ratliver (OLTX) and heart (HTX) transplant mod-
els and analyzed the mechamsms. 1.5 x 107 hamster 
hepatocytes (HC) or a minced heart as source of xenoan-
tigens were given to prospective recipients on day -6. with 
or without FK (I mg/kg/d x fl). OL TX and HTX were 
performed on day O. 
Xenoantigen alone induced HAR that correlated with 
high titer of complement-dependent cytotoxic antibody 
(CDC). Additionally. immunosuppression with FK resulted 
in prevention of HAR and improved survival of OLTX 
recipients in the first 3 postoperative weeks (l' < .05). with 
evidence of reduced antibody in the grafts. Even though FK 
did not eliminate total IgM amount and natural antibody 
titers. target-specific IgM. which is responsible for HAR. 
was reduced in the antigen ~ FK-treated group as com-
pared with that with antigen alone. Furthermore. the sera 
from long-term survivors of OL TX did not inhibit CDC 
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activity of sera obtained from animals experiencing HAR. 
This is contrary to reports by Braun et a!. t who showed an 
inhibitory effect of serum from an immunosuppressed pa-
tient. postulating a possible role for anti-idiotypic antibod-
ies. This preliminary evidence suggests that the inhibition of 
xenoantigen-specific IgM production by FK seems to play 
an important role in the acceptance of xenografts. 
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